ArticleOncotarget2016

FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.